Cefaclor & Linezolid and Their Effectiveness against S. Aureus

Kaixuan Jin

2022

Abstract

Staphylococcus aureus is a common human pathogen that could cause skin and soft tissue infection. Symptoms and severity of S. aureus SSTIs differ significantly, and complicated SSTI might require antibacterial agents to treat. Both linezolid and cefaclor are effective against S. aureus infections. Linezolid is an artificially synthesized antibacterial agent. It inhibits bacteria’s protein synthesis by binding to bacteria ribosome and prohibiting the translation at an early stage. It could be delivered orally or intravenously. Cefaclor is another human synthesized antibacterial agent. It could inhibit the synthesis of peptidoglycan by binding to a type of penicillin binding protein, causing bacteria cell wall lysis. It is delivered orally. In this work, the structures, mechanisms, limitations and economics of the two antibacterial agents would be briefly discussed and the comparison between them would be shown clearly.

Paper Citation

in Harvard Style

Jin K. (2022). Cefaclor & Linezolid and Their Effectiveness against S. Aureus. In Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB, ISBN 978-989-758-595-1, pages 774-779. DOI: 10.5220/0011295000003443

in Bibtex Style

@conference{icbeb22,
author={Kaixuan Jin},
title={Cefaclor & Linezolid and Their Effectiveness against S. Aureus},
booktitle={Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,},
year={2022},
pages={774-779},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011295000003443},
isbn={978-989-758-595-1},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,
TI - Cefaclor & Linezolid and Their Effectiveness against S. Aureus
SN - 978-989-758-595-1
AU - Jin K.
PY - 2022
SP - 774
EP - 779
DO - 10.5220/0011295000003443